核心观点 - 高盛一季度营收和利润均超预期，但股价因核心业务表现疲软及信贷损失拨备大增而下跌[1][14] - 投资者关注点从整体强劲的业绩转向固定收益交易业务的大幅不及预期以及信贷成本上升[1][8] - 地缘政治紧张局势（伊朗冲突）可能对未来交易活动和市场状况构成潜在阻力[1][9][10] 财务业绩摘要 - **整体业绩超预期**：一季度净利润为56.3亿美元，营收为172.3亿美元，每股收益为17.55美元，均超过分析师预期的每股收益16.49美元及营收约169.7亿美元[2] - **信贷损失拨备大增**：一季度信贷损失拨备约为3.15亿美元，是分析师预期约1.5亿美元的两倍多，为自2020年以来最大的贷款损失拨备增加[6][8] - **股票交易业务创纪录**：当季股票交易收入飙升至创纪录水平[12] - **投行业务费用强劲反弹**：随着交易活动增加，投资银行费用大幅反弹[12] 业务部门表现 - **固定收益、外汇和大宗商品交易大幅不及预期**：FICC业务收入约为40亿美元，比分析师预期低达9亿美元[4] - **资产与财富管理收入未达预期**：该部门产生40.8亿美元收入，比分析师预期低约1.4亿美元[5] - **投资银行业务显现韧性**：首席执行官表示交易活动保持韧性，并对交易达成持乐观态度[9][11] 管理层评论与展望 - **首席执行官对业绩持积极态度**：认为公司在市场波动加剧的情况下为股东带来了非常强劲的业绩，并对业务定位充满信心[9] - **关注地缘政治风险**：警告若伊朗及中东地区的冲突持续，可能对交易活动和市场活动造成压力，并影响通胀趋势[1][9][10] - **对交易环境持谨慎乐观**：高管认为有机会推动规模和整合，但分析师警告投行业务若长期无实质增长或市场降温可能导致失望和剧烈调整[11][12] 市场反应与同业比较 - **股价下跌**：尽管业绩超预期，股价盘中下跌约2%，开盘一度暴跌超4%[1] - **同业股价表现**：摩根大通股价上涨约0.8%，美国银行股价上涨约0.7%，反映大型银行股情绪略偏积极[13] - **行业指数表现平淡**：更广泛的KBW银行指数基本持平，Invesco KBW Bank ETF交易价格在80美元中段区间[13]

事件概述 - 英伟达公司正式否认了网站SemiAccurate关于其寻求收购一家大型个人电脑制造商的报道，该报道称此举将“重塑个人电脑行业格局” [1][4] - 该不实报道曾引发市场波动，导致戴尔科技和惠普公司股价在周一（常规交易时段）显著上涨 [1][3][4][6] 相关公司市场地位 - 根据Gartner数据，惠普是全球第二大个人电脑供应商，第一季度全球市场份额为19%，仅次于市场份额接近27%的联想集团 [2][5] - 戴尔是全球主要个人电脑供应商之一，第一季度全球市场份额约为17% [2][5] - 英伟达是全球市值最高的公司，同时也是最大的人工智能芯片制造商 [2][5] 公司业务与战略 - 英伟达首席执行官黄仁勋是推动人工智能技术在整个经济领域应用的主要倡导者之一 [2][5] - 在截至1月份的上一财年，英伟达向合作伙伴和客户投资了700亿美元以推动人工智能发展 [3][6] - 戴尔是英伟达的合作伙伴，生产使用英伟达芯片的人工智能服务器，并预测在截至2027年1月的本财年，其人工智能服务器业务将带来约500亿美元收入 [3][6] 市场反应 - 在英伟达发表否认评论后，戴尔股价在盘后交易中下跌3.4%，此前该股在常规交易时段上涨6.7%，收于创纪录的189.79美元 [3][6] - 在英伟达发表否认评论后，惠普股价在盘后交易中下跌超过3%，此前该股在常规交易时段上涨5.3%，收于19.23美元 [3][6]

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its ...

Kelowna, British Columbia – April 13, 2026 - TheNewswire – Rize Oncology Inc. (the "Company"), a clinical- stage pharmaceutical company focused on developing innovative oncology therapeutics, is pleased to announce the implementation of a warrant incentive program (the "Incentive Program") designed to encourage the exercise of existing common share purchase warrants of the Company. The Incentive Program is being implemented with respect to: (i) 25,000,000 common share purchase warrants initially issued on J ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Atara To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Atara between May 20, 2024 and January 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212- 983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - April 13, 2026) - Fa ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In PayPal To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in PayPal between February 25, 2025 and February 2, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - April 13, 2026 ...

Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds and exchange-traded funds. Nick has previously held Series 7 and Series 66 licenses and has been investing personally for over 14 years.He contributes to the investing group CEF/ETF Income Laboratory along with leader Stanford Chemist, and Juan de la Hoz and Dividend Seeker. They help members benefit from income and arbitrage strategies in CEFs and ETFs by providing expert-level research. The service inc ...

PORTLAND, Maine, April 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops and markets products to improve calf health and productivity, announced that Dr. Gilles Guillemette and Dr. Anthony DiMarco have been appointed to its Board of Directors, effective April 15, 2026. The Company also announced it is moving to a 7-person Board of Directors with six Independent Directors and the CEO, and that it will create a Stra ...

文章核心观点 - 文章提出一个以四只Vanguard ETF为核心的、成本低廉的千美元投资组合构建方案 旨在通过覆盖美国大盘、美国价值、能源行业和国际市场这四个关键维度 为投资者提供应对任何市场环境的多元化核心持仓[1][3][20] Vanguard S&P 500 ETF (VOO) - 该基金是追踪标普500指数的核心持仓 费率仅为0.03% 管理资产规模达1.4万亿美元[1][4] - 投资组合高度集中于科技行业 信息技术板块权重达33% 仅英伟达单一持仓占比就约为7% 前三大持仓合计约占基金总资产的19%[1][5] - 长期回报强劲 过去一年上涨31% 十年回报率约为291% 但年初至今表现基本持平 截至四月初微跌不到1%[5] - 基金提供1.13%的股息收益率[6] Vanguard Value ETF (VTV) - 该基金追踪CRSP美国大盘价值指数 与VOO持仓公司相似但权重结构不同 重点配置金融、医疗保健和工业板块 合计占比近48%[7][8] - 前几大持仓包括伯克希尔·哈撒韦(约3%)、摩根大通(约3%)、埃克森美孚(约2.5%)和强生(约2.3%)[9] - 基金股息收益率为1.97% 几乎是VOO的两倍 费率同样为0.03%[1][9] - 年初至今表现优于大盘 上涨约6% 而VOO同期基本持平 但其十年回报率214%落后于VOO的291% 反映了过去十年成长股的主导地位[10] - 当前十年期国债收益率接近4.3%的环境 更有利于金融和公用事业等价值型板块 而非长久期成长股[10] Vanguard Energy ETF (VDE) - 该基金是主题最明确的基金 投资组合中98%为能源板块 埃克森美孚和雪佛龙两家公司合计权重约37%[12] - 基金覆盖能源行业全产业链 包括上游勘探、中游管道、炼化和油田服务[12] - 当前WTI原油价格接近每桶114美元 仅过去一个月就上涨约26% 推动基金年初至今上涨29% 过去一年上涨56% 表现远超大盘[1][13] - 基金股息收益率为2.43% 费率为0.09% 五年回报率达189% 反映了自2020年低点以来能源股强劲的复利增长[14] Vanguard Total International Stock ETF (VXUS) - 该基金追踪富时全球除美国全盘指数 覆盖美国以外的发达和新兴市场 管理资产规模超过5820亿美元 费率仅为0.05%[1][16] - 在地理和行业配置上 前几大持仓偏向科技、金融和能源板块 包括台积电、三星和ASML控股等公司 股息收益率接近3%[17] - 年初至今表现强劲 上涨近8% 大幅跑赢表现持平的VOO 过去一年上涨44%[1][18] - 表现优异主要受美元走软以及欧亚市场估值相对于美国大型科技股较低所驱动[1][18] - 但该基金五年回报率为49% 落后于VOO同期的77%[19] 市场环境与资金轮动 - VIX波动率指数在2026年3月底曾升至31以上 随后在4月中旬回落至19左右 这种先急剧飙升后迅速正常化的波动周期 历史上与长期指数投资者活跃度增加相吻合[3] - 波动率周期和美元走软促使长期指数投资者在Vanguard核心持仓中进行轮动 价值型基金和国际敞口基金正从侧重科技的美国宽基跟踪基金中获得资金流入[2]

Managers who focus on exits and returning capital to investors are "more likely to succeed" when raising their next funds, while managers who don't generate distributions will struggle to raise capital and attract talent," the report noted. GPs also noted that they expect fewer companies to pursue IPOs this year, alongside continued pressure on corporate valuations. Despite this, With Intelligence reported that exit activity will at least normalize this year. A Challenging Time For Private Equity According ...